Posted by Michael Wonder on 02 Feb 2022
ATAGI recommendations for use of Pfizer COVID-19 vaccine as a booster dose in adolescents aged 16-17 years
3 January 2022 - The Australian Technical Advisory Group on Immunisation (ATAGI) has made recommendations for use of Pfizer COVID-19 vaccine as a booster dose in adolescents aged 16-17 years.
Comirnaty (Pfizer) was registered by the TGA on 28 January 2022 for use as a booster in the 16–17 year age group. ATAGI now extends the recommendation of a booster dose to include all individuals aged 16-17 years.
